<DOC>
	<DOCNO>NCT01127256</DOCNO>
	<brief_summary>The purpose study compare efficacy safety zonisamide carbamazepine determine optimum dose zonisamide patient epilepsy .</brief_summary>
	<brief_title>Comparative Study Zonisamide Carbamazepine Initial Monotherapy : Efficacy Safety Evaluation</brief_title>
	<detailed_description>To compare efficacy safety zonisamide group carbamazepine group . The zonisamide group divide 2 subgroup : Slow-titration group Fast-titration group find optimum titration zonisamide . This study proceed 25~27 week .</detailed_description>
	<mesh_term>Zonisamide</mesh_term>
	<mesh_term>Carbamazepine</mesh_term>
	<criteria>Inclusion criterion : 1 . Epilepsy patient 15 year old . 2 . Occurrence seizure one time within recent 3 month two time within recent 6 month . 3 . Patients take antiepileptic drug ( AEDs ) recent 3 month . 4 . Female month pregnancy agree prevent conception . 5 . Patients agree Informed Consent Form . Exclusion criterion : 1 . Patients Myoclonic seizure and/or Absence seizure . 2 . Patients progressive central nervous system ( CNS ) disorder . 3 . Patients serious systemic disorder . 4 . Upward double normal serum glutamic oxaloacetic transaminase ( SGOT ) serum glutamic pyruvic transaminase ( SGPT ) level and/or triple blood urea nitrogen ( BUN ) /Creatinine level . 5 . Patients renal stone . 6 . Medical history medicinal poisoning and/or alcoholism . 7 . Patients longterm medication history ( 6 month ) zonisamide and/or carbamazepine .</criteria>
	<gender>All</gender>
	<minimum_age>15 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>May 2010</verification_date>
</DOC>